about
Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 AcquisitionImmunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized Mice.Qualified Biolayer Interferometry Avidity Measurements Distinguish the Heterogeneity of Antibody Interactions with Circumsporozoite Protein AntigensControl of Heterologous Simian Immunodeficiency Virus SIV Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in MacaquesRare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccinesEngagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisitionImpact of Th1 CD4 Follicular Helper T Cell Skewing on Antibody Responses to an HIV-1 Vaccine in Rhesus MacaquesBridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal ModelsAntibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials
P50
Q36290038-AC1A5A90-0C59-46CC-B8AE-0A87DFB606DCQ37261545-AE001262-4D37-4018-AABB-FD4AE973E07AQ40409324-F3BEC5E3-409E-425E-8E70-5EAEBA9C5A0DQ56342409-5728C347-3A66-46CC-9EF1-34F569D10674Q56517308-A73710D6-3736-46F5-80A5-C659F12D9FC0Q62487341-E13B91E9-89B6-4B1A-A85C-32DA78F78B24Q89857234-AE0054D1-AA81-4705-B57B-CFD029C11DC0Q90263714-FA01E9F3-A3A9-48D2-AD0B-4134B1C36649Q91890380-1E3BFF9B-BC1C-4601-9A87-663E669B3F8FQ92177871-BC5E063B-6CFF-4EF4-BF0A-50A4D412561AQ95649524-05269A9C-F6BA-4C94-AC22-7D4C03659A89
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Georgia D Tomaras
@en
Georgia D Tomaras
@nl
type
label
Georgia D Tomaras
@en
Georgia D Tomaras
@nl
prefLabel
Georgia D Tomaras
@en
Georgia D Tomaras
@nl
P31
P496
0000-0001-8076-1931